MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R

LEUKEMIA & LYMPHOMA

TAYLOR & FRANCIS LTD

1. Intramural NIH HHS [Z01 SC000550-27] Funding Source: Medline
2. NATIONAL CANCER INSTITUTE [ZIASC000550, ZIABC011070, ZIDBC011792] Funding Source: NIH RePORTER